Bioprosthetic surgical aortic valve replacement (sAVR) is increasingly adopted in younger patients to avoid lifelong anticoagulation. For informed decisions, knowledge of the real-world outcome of such a choice is critical.
Bioprosthetic Surgical Aortic Valve Replacement in Patients under the Age of 60 Years / De Paulis, R.; Senage, T.; Borger, M. A.; Siepe, M.; Stefano, P.; Laufer, G.; Langanay, T.; Meuris, B.. - In: THE CARDIOTHORACIC SURGEON. - ISSN 2662-2203. - ELETTRONICO. - 70:(2022), pp. 0-0. [10.1055/s-0042-1742944]
Bioprosthetic Surgical Aortic Valve Replacement in Patients under the Age of 60 Years
Stefano, P.;
2022
Abstract
Bioprosthetic surgical aortic valve replacement (sAVR) is increasingly adopted in younger patients to avoid lifelong anticoagulation. For informed decisions, knowledge of the real-world outcome of such a choice is critical.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
